The Tumor Microenvironment not only is a major factor influencing treatment resistance to conventional anticancer therapies, malignant progression and metastatic potential, but its uniqueness also offers the potential for the development of novel cancer treatment strategies.

This workshop focuses on the characteristics of the tumor microenvironment, its role in resistance to radiotherapy and chemotherapy, and novel treatments designed to overcome this resistance,  It will also drive new knowledge in areas ranging from cellular and molecular biology, physiology, biochemistry, and pharmacology to drug development and the design of combined modality and molecular targeting approaches.  Preclinicaland clinical perspectives will be presented by laboratory and physician scientists interested in the tumor microenvironment.

Workshop Topics

Molecular Signatures & Signaling
Imaging, Biomarkers & Therapy Prediction
Stroma, Niches & Stem Cells
Tumor Hypoxia-Overcoming Radiotherapeutic and Other forms of Resistance
Exploiting the Microenvironment for Novel Therapies
Blood Vessel Directed Therapies

Workshop Format

Each session will be introduced by a keynote lecture followed by 8-10 minute oral presentations selected from submitted abstracts.  There will be no poster sessions, and no competing sessions.